Phesgo and Tecentriq Performance and Approvals slide image

Phesgo and Tecentriq Performance and Approvals

Exchange rate impact on sales growth Negative impact driven by the JPY, EUR and CNY CER sales growth Q1 2023 VS. Q1 2022 -3.1% -0.7p +0.1p -0.9p -0.4p -1.2p -0.2p -0.4p -6.8% CER EUR APAC USD LATAM JPY Other Other Europe CHF CER = Constant Exchange Rates (avg full year 2022) Roche CHF sales growth Q1 2023 VS. Q1 2022 46 46
View entire presentation